Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2017
Jan. 31, 2017
Current assets:    
Cash and cash equivalents $ 27,155 $ 28,302
Restricted cash 8 109
Marketable securities 4,990 5,253
Accounts and other receivables, net of allowance for doubtful accounts of $294 and $876 at October 31, 2017 and January 31, 2017, respectively 28,437 25,985
Unbilled receivables 3,630 6,553
Inventories, net 850 770
Prepaid expenses and other current assets 2,856 2,393
Total current assets 67,926 69,365
Property and equipment, net 10,131 11,485
Marketable securities, long-term 4,485 4,991
Investments in affiliates 2,000 2,000
Intangible assets, net 1,616 2,603
Goodwill, net 24,506 23,287
Other assets 1,200 2,336
Total assets 111,864 116,067
Current liabilities:    
Accounts payable 1,631 4,978
Deferred revenues 12,558 12,517
Other accrued expenses 12,788 9,928
Total current liabilities 26,977 27,423
Deferred revenue, long-term 3,058 2,419
Deferred tax liabilities, long-term 16,253 14,732
Taxes payable, long-term 973 1,427
Other liabilities, long-term   530
Total liabilities 47,261 46,531
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, $0.01 par value; 100,000,000 shares authorized; 35,544,361 shares issued and 35,503,871 outstanding at October 31, 2017, and 35,339,232 shares issued and 35,298,742 outstanding at January 31, 2017 355 353
Additional paid-in capital 238,955 236,677
Treasury stock, at cost; 40,490 common shares at October 31, 2017 and January 31, 2017, respectively (5) (5)
Accumulated loss (169,238) (162,118)
Accumulated other comprehensive loss (5,464) (5,371)
Total stockholders’ equity 64,603 69,536
Total liabilities and stockholders’ equity $ 111,864 $ 116,067